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Abstract
Background: Mutations of the superoxide dismutase 1 (SOD1) gene are linked to amyotrophic
lateral sclerosis (ALS), an invariably fatal neurological condition involving cortico-spinal
degeneration. Mechanical injury can also determine spinal cord degeneration and act as a risk factor
for the development of ALS.
Results: We have performed a comparative ontological analysis of the gene expression profiles of
thoracic cord samples from rats carrying the G93A SOD1 gene mutation and from wild-type
littermates subjected to mechanical compression of the spinal cord. Common molecular responses
and gene expression changes unique to each experimental paradigm were evaluated against the
functional development of each animal model. Gene Ontology categories crucial to protein folding,
extracellular matrix and axonal formation underwent early activation in both experimental
paradigms, but decreased significantly in the spinal cord from animals recovering from injury after
7 days and from the G93A SOD1 mutant rats at end-stage disease. Functional improvement after
compression coincided with a massive up-regulation of growth-promoting gene categories
including factors involved in angiogenesis and transcription, overcoming the more transitory surge
of pro-apoptotic components and cell-cycle genes. The cord from G93A SOD1 mutants showed
persistent over-expression of apoptotic and stress molecules with fewer neurorestorative signals,
while functional deterioration was ongoing.
Conclusion: this study illustrates how cytoskeletal protein metabolism is central to trauma and
genetically-induced spinal cord degeneration and elucidates the main molecular events
accompanying functional recovery or decline in two different animal models of spinal cord
degeneration.
Background
Spinal cord degeneration in humans resulting from a
mechanical injury or developing in the context of a neu-
rodegenerative disorder causes a variable degree of neuro-
logical disability. Functional recovery after a mechanical
insult to the spinal cord depends on the force and site of
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impact, on the duration of uninterrupted compression
and possibly, on a genetically-determined ability of the
nervous tissue to activate repair mechanisms. Similarly,
non-traumatic neurodegenerative disorders affecting the
spinal cord present a wide range of clinical variability.
Amyotrophic lateral sclerosis/motor neuron disease (ALS/
MND), for example, leads almost invariably to death from
respiratory failure on average in 3 to 5 years from disease
onset, as a result of widespread motor cell loss. However,
survival rates of up to 15 years have been described, along
with ALS cases who survive no more than 6 months [1].
Clinical heterogeneity has also been described in those
20% of familial ALS cases linked to mutations of the
superoxide dismutase 1 (SOD1) gene, a genetic defect that
exhibits a toxic gain of function that adversely affects
motor neurons [2-4]. The molecular determinants that
modulate the course of trauma-induced and genetically-
induced spinal cord degeneration are still largely elusive.
Spinal cord vulnerability may be linked to disease modi-
fiers that are activated by selective disease processes but
also depends on a common ground of molecular factors
that can be switched on by different pathological triggers.
Recent epidemiological observations strengthen the case
for the search for molecular mechanism of spinal cord tis-
sue degeneration that may be activated by different path-
ological determinants. Cervical trauma has been singled
out as one of the main risk factors for the development of
ALS and this deadly neurological disorder seems to be
seven times more prevalent in a large cohort of profes-
sional footballers in Italy [5].
How biomechanical stress initiates the cascade of molec-
ular events leading to the irreversible neurodegeneration
observed in ALS is not known. We can postulate that the
impact may accelerate a pathological process already
ongoing or precipitate a detrimental tissue response that
ultimately triggers the disease in genetically susceptible
individuals. Novel techniques of gene expression and pro-
teomic analysis have been applied to obtain a better
understanding of the molecular events underlying trauma
or genetically-induced degeneration. In spinal cord from
animal models of spinal cord injury (SCI) and ALS, simi-
lar to what is observed in post-mortem spinal cord from
ALS individuals, a time-dependent and coordinated
expression of functionally synergistic gene candidates has
been reported. This includes an early differential expres-
sion of components of the cytoskeleton, of the neuro-
transmission machinery and of genes involved in lipid
metabolism, protein kinase regulation, antioxidant activ-
ity, lysosomal function, ion transport, transcription and
inflammation [6-8]. 24 hours from mechanical trauma,
the gene expression profile in spinal cord switches
towards the activation of growth, axonal guidance, ang-
iogenic, cell cycle and extracellular matrix factors while
activated macrophages accumulate in the damaged tissue
[9-13]. The ALS spinal cord molecular profile after disease
onset shows the differential regulation of a wide range of
inflammatory and stress-related molecular factors and of
genes involved in zinc/copper and cholesterol homeosta-
sis [7,14,15]. The role of these molecular pathways in pre-
serving and restoring tissue functional integrity is not
entirely clear. For example, in both SCI and in ALS animal
models, the activation of inflammatory genes has been
described in affected tissues but we do not know whether
these responses have a detrimental effect on tissue regen-
eration [16,10,7,11,14,15]. A consensus exists about the
effects of other trauma-induced gene expression changes,
such as the post-injury secretion from activated astrocytes
of anti-regenerative molecules like chondroitin sulphate
proteoglycans and of the pro-regenerative factors laminin
and fibronectin. The balance between these factors condi-
tions gial scarring, which limits axonal regeneration [17].
Despite the wealth of data available, no study has
attempted to amalgamate different experimental condi-
tions to evaluate the role of specific molecular pathways
in the context of functional recovery or decline, or to
investigate the molecular interplay between trauma-
induced and idiopathic degeneration.
In this study, we have analysed the biological significance
of the temporal gene expression changes occurring in spi-
nal cord degeneration induced by mechanical injury or
determined by the G93A SOD1 gene mutation. We have
used a bioinformatics approach (High-Throughput GoM-
iner) which allows the integration of different gene
expression datasets, the dissection of Gene Ontology
(GO) categories containing gene candidates sharing a
similar functional role from the most significantly differ-
entially expressed genes, and a comparative evaluation of
the significance of these gene categories. To minimise dif-
ferences inherent to the genetic background of the animal
models, we have compared Sprague Dawley rats carrying
the G93A SOD1 gene mutation with their wild type litter-
mates after spinal cord compression injury. Longitudinal
gene expression analyses were obtained at different time
points within a week from spinal cord compression injury
and at a pre-symptomatic stage, at disease onset and end-
stage in the G93A SOD1 mutant rats. In these time-win-
dows, both experimental paradigms of spinal cord degen-
eration display a remarkable degree of motor cell loss, in
association with the development of a significant loco-
motor improvement in the rat model of spinal cord com-
pression (SCC) and of an irreversible functional decline in
the rat model of ALS. The integrative analysis of a large
group of molecular pathways acting within situations of
acute and chronic degeneration that lead to completely
different functional outcomes, provides a better under-
standing of the role of these molecular cascades in neuro-
degeneration. We have chosen the 30 minutes, 4 hours,
24 hours and 7 days time points for our experimentalBMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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observations after SCC, to allow direct comparison with
previous gene expression data generated by a similar
investigation into the effects of a mild spinal cord injury
[11] and with published histological data on the rat SCC
model [18]. This study aims at advancing our understand-
ing of spinal cord degeneration in two major areas: a) the
identification of those molecular changes induced by
mechanical trauma that may set the course of irreversible
degeneration as seen in ALS, b) the main driving forces
behind functional decline and recovery in genetically-
induced and traumatic spinal cord degeneration.
Results and discussion
Behavioural and locomotor changes in the rat models of 
spinal cord compression and amyotrophic lateral sclerosis: 
histopathological correlations
The Basso, Beattie, and Bresnahan (BBB) open-field loco-
motor rating scale was applied to evaluate functional
recovery after spinal cord compression (SCC). Figure 1C
displays the curve of functional recovery according to BBB
assessment in spinal cord compression (SCC) performed
using 35 g. weight (red colour code; 0 represents hindlimb
complete paralysis, 15 represents full weight support and
forelimb/hindlimb coordination but incomplete toe
clearance, 21 represents normal function) [18]. To dem-
onstrate the effects of spinal cord compression (SCC)
induced by a heavier weight, we have plotted in the same
graph the previously reported data obtained using a 50 g
compression injury model [18]. In rats subjected to a 35 g
SCC, the Basso, Beattie, and Bresnahan (BBB) scoring
showed the highest level of post-injury disability in the
period between 4 hours and 24 hours after mechanical
compression, followed by a steady recovery on day 2 and
by a more gradual improvement to the final measurement
at day 7 after injury.
Serial weight measurements of the G93A SOD1 mutant
rats were performed from 7 weeks of age and the maxi-
mum body weight in pre-symptomatic rats was recorded.
As already described [16], the body weight of the G93A
SOD1 mutant rats is reduced by up to 10% of their maxi-
mum body weight when the first signs of paralysis
become detectable (disease onset: 129 +/- 17.3 days of
age; Figure 1B, T0), on average 6 days after the measure-
ment of the maximum body weight (Figure 1B). Progres-
sion to the final stage of the disease (defined as weight
reduction of 25% from maximum body weight), was very
rapid and it was complete in approximately 7 days from
disease onset (disease end-stage: 139 +/- 17 days of age;
Figure 1B). Figure 1(A1, A2) reports previously published
data obtained from a behavioural analysis of the G93A
SOD1 mutant rats, outlining the increase of immobility
time already evident at onset of the first symptoms accom-
panied by a reduction of rearing episodes. Late-stage dis-
ease in mutant animals is characterised by the significant
increase of immobility time and by the reduction of rear-
ing episodes [16].
It is possible to correlate the changes involving functional
and behavioural aspects of the disease development in the
animal models employed in this study, with the main
pathological changes that have been previously described
in the spinal cord from these models of neurodegenera-
tion [16,18]. For example, the initial subtle signs of dis-
ease accompanied by a substantial weight loss in the
G93A SOD1 mutant rat are associated with an already
established reduction of the motor cell population, glial
activation, axonal loss, infiltration of inflammatory cells
and derangement of the intracellular architecture with the
appearance of inclusion bodies [16,38]. While minor ele-
ments of tissue structural alteration are already present in
an early pre-symptomatic stage, the pace of spinal cord tis-
sue degeneration in the G93A SOD1 mutant rat acceler-
ates from the onset to the advanced stage of the disease, in
concert with the dramatic functional decline and weight
loss described in this transgenic model of ALS (Figure 1
A1/A2/B).
Likewise, the functional effects of a 50 g spinal cord com-
pression have been thoroughly described, together with
the main pathological features of spinal cord degenera-
tion developing in this type of mechanical injury [16].
Studies of spinal cord injury using static compression
have highlighted that neuronal loss is much more pro-
tracted in time in this type of trauma, than the loss
observed after contusion injury. While neuronal death fol-
lowing contusion is an acute event that is largely over after
24 hours, loss of neuronal cells after compression injury
at the injury epicentre involves approximately 43% in the
first day and extends to 73% of the whole neuronal cell
population at 3 days after the impact. In this time-win-
dow, glial cells are also likely to become involved and the
spinal cord tissue pathology is dominated by inflamma-
tory responses including macrophage activation. The mas-
sive neuronal loss and the effects that mechanical
compression exerts on cortico-spinal function explain the
significant locomotor impairment in our animal model of
compression injury in the first day post-injury. The much
slower pace of neuronal loss from the second day after the
trauma, together with the activation of a number of tissue-
repair mechanism as reported later on in this paper, gives
a reason for the remarkable functional recovery observed
after the first day, particularly between 24 and 48 hours in
the post-injury time-frame.
Comparative gene ontology analysis of the time-
dependent spinal cord molecular profiles induced by 
compression and by the G93A SOD1 gene mutation
We have compared the thoracic cord molecular profiles of
the G93A SOD1 mutant spinal cord obtained from ani-BMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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Figure 1 (see legend on next page)
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mals at a pre-symptomatic, at onset and at end-stage dis-
ease, to the thoracic cord molecular profiles after spinal
cord compression (SCC) and sham-operation at 30 min-
utes and 4 hours, and after spinal cord compression
(SCC) at 24 hours and 7 days from the trauma. We have
used the Illumina Bead-arrays (Illumina, San Diego, USA)
to generate a total of 12 gene expression datasets from
thoracic spinal cord samples, harvested from the above
animal models at the specified time-points. These include
the expression profiles of pooled thoracic cord samples at
30 minutes, 4 hours, 24 hours and 7 days from injury, at
30 minutes and 4 hours from sham-operation and the
expression profile of pooled SOD1 G93A mutant thoracic
cord samples and of pooled wild type (WT) littermates at
a pre-symptomatic stage (10 weeks of age), at onset and at
end-stage disease. Differential gene expression analysis
was obtained comparing the expression profiles of the
injured, sham-operated and SOD1 G93A mutant spinal
cord pools with wild type (WT) pooled spinal cord tissues
at the specified time points (the expression profile of the
10-week old WT thoracic cord was used as control to iden-
tify differential expression in injured spinal cord; numbers
of differentially-regulated genes in thoracic spinal cord :
11 in pre-symptomatic G93A SOD1 mutant, 98 in disease
onset G93A SOD1 mutant, 300 in disease end-stage G93A
SOD1mutant; 112 genes in thoracic cord 30 minutes after
compression, 27 genes in thoracic cord 30 minutes after
laminectomy; 141 genes in thoracic cord 4 hours after
compression; 42 genes in thoracic cord 4 hours after lam-
inectomy; 318 genes in thoracic cord 24 hours after com-
pression; 422 genes in thoracic cord 7 days after
compression, Figure 2; "differentially regulated genes")
and 9 lists of differentially-regulated gene candidates were
generated and used for further ontological analysis using
High-throughput GoMiner. A separate Bead-chip was
used for the gene expression analysis of pools of lumbar
spinal cord samples from G93A SOD1 mutant rats at a
pre-symptomatic stage, at onset and at end-stage disease
and from wild type littermates.
We have used High-Throughput GoMiner http://dis
cover.nci.nih.gov/gominer/htgm.jsp to integrate the spi-
nal cord gene expression data into a coherent picture of
biological processes. This program provides a biological
interpretation for the lists of under- and over-expressed
genes generated by a microarray experiment, clustering
functionally synergistic genes into Gene Ontology (GO)
categories. The software defines those GO categories
Graphs illustrating the profiles of functional, behavioural and weight changes recorded in the models of trauma and genetically- induced spinal cord degeneration employed in this study Figure 1 (see previous page)
Graphs illustrating the profiles of functional, behavioural and weight changes recorded in the models of 
trauma and genetically-induced spinal cord degeneration employed in this study. The functional and behavioural 
analyses include the open-field locomotor assessment (BBB score) of rats after mild spinal cord compression and the evalua-
tion of immobility time and rearing episodes in G93A SOD1 mutant rats. For comparison, we report previously published data 
generated from similar experimental platforms (data taken from Jokic et al. 2007 and Huang et al. 2007) [16,18]. A1 – A2: 
Schematic representation of the average immobility time (A2) and average number of rearing episodes (A1) observed in 4 
G93A SOD1 mutant rats with subtle signs of hindlimb paralysis at disease presentation and in 4 wild type rats. Determinations 
by independent observers were performed at onset and at end-stage disease, based on 2 subsequent 3-minutes video clips 
recorded during disease development in the 4 G93A SOD1 mutant rats and in the WT littermates. Data previously reported by 
Jokic et al. [16]. At disease onset, the duration of average immobility time in the wild-type and in the G93A SOD1 mutant ani-
mals was similar, whereas a significant increase in duration of immobility time was observed in the G93A SOD1 mutant animals 
at end stage disease (A2; p < 0.05, ANOVA). A remarkable reduction of rearing episodes is seen in G93A SOD1 mutant rats at 
end-stage disease (A1; p < 0.001, ANOVA). Disease onset (appearance of first signs of paralysis): 129 +/- 17.3 days. End-stage 
disease (25–30% loss of body weight): 139 +/- 17 days. B: Individual body weight measurements of 12 G93A SOD1 mutant rats 
and of 12 age-matched wild type animals from a pre-symptomatic stage to end-stage disease (G93A SOD1 mutant rats pre-
sented with either hindlimb or forelimb paralysis at disease onset). The data presented include previous observations obtained 
from a group of 4 G93A SOD1 mutant rats and 4 wild type rats [16]. The maximum body weight recorded for each G93A SOD1 
mutant rat was set at 100% as base-line. The graph indicates body weight measurements performed after this point (the meas-
urements started at 7 weeks of age and were performed every two days), expressed as percentage of the maximum body 
weight. Disease onset (T0) is indicated at the time of the appearance of the first signs of paralysis (on average at 129 +/- 17.3 
days of age). At disease onset, weight loss has been progressing for at least 6 days to a 10 to 15% reduction from maximum 
body weight. The end-stage disease was set at 25–30% of weight loss (139 +/- 17 days of age in the G93A SOD1 mutants). 
Weight measurements are expressed as averages of weight determinations of the number of surviving animals reported in the 
graph (those rats reaching a 25–30% body weight reduction were sacrificed). The graph reports the numbers of surviving ani-
mals at each time point. C: the graph illustrates the functional recovery of wild-type female rats after spinal cord compression, 
measured at 30 minutes, 4 hours, 24 hours and 7 days from mild injury (35 g weight spinal cord compression) using the Basso, 
Beattie, and Bresnahan (BBB) open-field locomotor assessment. The BBB scoring for each 5 animals right and left hindlimb was 
graded at the defined time points by two independent blinded observers (red colour code). Also plotted are the BBB scores of 
Sprague-Dawley rats after a 50 g compression injury (blue colour code, n: 5), taken from previously reported data [18].BMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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which are more represented within the total of differen-
tially expressed genes according to a gene enrichment
principle (number of genes of a specific GO category in
the pool of differentially regulated genes) and according
to a false discovery rate (FDR).
High-throughput GoMiner analysis of the 9 text files
enlisting the changed genes generated a total of 232 GO
categories with a significant differential regulation at one
or more time points in the two experimental conditions,
including 166 up-regulated and 66 down-regulated GO
categories (FDR < 0.05). The 232 GO categories were
grouped under specific functional headings, according to
their parent-child relationship as well as their functional
and biological affinity (Figure 2; "Functional Headings";
GO***: number of GO categories in each functional
heading).
To illustrate the level of differential regulation of each
functional heading at a specific experimental time point
for the SCC and the G93A SOD1 mutant spinal cords, we
have calculated the average of the FDR values (aFDR) of
the GO categories included in each functional heading at
all time points considered in the two experimental condi-
tions. Averages at each time point were obtained from
both significant FDRs (< 0.05) and non significant FDRs
(>0.05 – non-significant FDR were given the value of 1),
computed for the GO categories included in each func-
tional heading (Additional files 1, 2, 3 and 4 report the
GO categories and FDRs included in the functional head-
ings displayed in Figure 2A, B, C and 2D). Average FDRs
(aFDR) were displayed in a heat chart with a colour code
scale, the lighter colours representing a higher level and
the darker colours a lower level of average statistical signif-
icance (Figure 2). Each aFDR colour in the heat-chart cov-
ers a range of FDR values, expressing the standard error of
each calculation (Figure 2). As an example, Figure 3 pro-
vides information on the "Development, Growth" func-
tional heading, its content in GO categories and the
aFDRs calculated for each time points in the SCC and ALS
experiments. Figure 2 displays functional headings whose
GO categories are up-regulated predominantly in SCC (A;
some headings are also represented in the SOD1 G93A
mutant spinal cord), in both SCC and SOD1 G93A
mutant cord samples (B), only in the SOD1 G93A mutant
cord samples (C) or down-regulated in both SCC and
SOD1 G93A mutant cord samples (D; see Additional files
1, 2, 3 and 4 respectively).
The GO categories and functional headings found to be
significantly activated in sham-operated animals at 30
minutes and 4 hours were also differentially regulated in
spinal cord from injured animals, including GO catego-
ries for chemokines, angiogenesis, taxis, cell migration/
motility, growth/differentiation and microtubule forma-
tion (Figure 2). However, the difference in aFDR values of
the functional headings common to injured and sham-
operated spinal cord samples, demonstrated that gene
expression changes were clearly more significant in the
injured spinal cord. While the level of "Development,
growth" functional heading activation at 4 hours is simi-
lar in injured and sham-operated animals, this functional
heading's GO categories become more significantly up-
regulated in injured spinal cord at 24 hours and 7 days
from injury (Figure 2A). These data are in line with the
previous observations of an early activation of a similar
Comparative ontological characterisation of the time-dependent spinal cord gene expression profiles obtained from animal  models of spinal cord compression and G93A SOD1 mutant rats using Bead array technology (Illumina) and High-Throughput  GoMiner Figure 2 (see previous page)
Comparative ontological characterisation of the time-dependent spinal cord gene expression profiles obtained 
from animal models of spinal cord compression and G93A SOD1 mutant rats using Bead array technology (Illu-
mina) and High-Throughput GoMiner. The heat chart reports the main functional headings containing clusters of parent-
child and functionally related Gene ontology (GO) categories (total output from High-Throughput GoMiner: 232 GO catego-
ries) obtained from the 9 subsets of differentially expressed genes. The 9 subsets of differentially regulated genes have been 
obtained comparing thoracic cord at 30 minutes, 4 hours, 24 hours and 7 days after compression injury and at 30 minutes and 
4 hours after laminectomy with healthy 10-weeks old spinal cord, and comparing the G93A SOD1 mutant spinal cord from ani-
mals at a pre-symptomatic stage, at onset and at end-stage disease with spinal cord from wild-type littermates at pre-sympto-
matic, onset and end-stage disease time-points. GO categories are computed from the 9 text files containing the changed genes 
by High-Throughput GoMiner, according to estimations of significance by false discovery rate (FDR, cut off <0.05). The func-
tional headings contain GO categories identified as significantly up-regulated predominantly in the spinal cord compression 
molecular profiles (A), in both G93A SOD1 mutant and injured spinal cord (B), and only in the spinal cord from the G93A SOD1 
mutant animals (C). Functional headings down-regulated in spinal cord from both experimental conditions are also reported 
(D). The degree of differential regulation of each functional heading is expressed at a specific time point as the average of the 
false discovery rates (aFDR) of all the functional heading's GO categories at this specific time-point and represented in the 
heat-chart with a colour code, in which lighter colours represent a higher level of differential regulation and the darker ones a 
lower level of differential regulation. "Differentially regulated": number of genes differentially regulated found in spinal cord 
gene expression analysis at each time point in the two experimental coditions. Sham*: 30 minutes after sham operation. 
Sham**: 4 hours after sham operation. GO***: number of GO categories in each functional heading. ****: transport of ions, 
neurotransmitters, potassium, calcium. *****: striated muscle, sarcomere, myosin, thick filaments.BMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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profile of molecular pathways, following both direct
trauma to the spinal cord and sham operation [12]. The
stress induced by simple laminectomy can have an effect
on spinal cord tissue which partially reproduces the
changes induced by traumatic injury. Gene expression
alterations induced in spinal cord tissue by an indirect
environmental stressor like a surgical operation may be
also relevant for the development of tissue degeneration.
This will be further discussed later in this paper.
Gene expression analysis: data reproducibility
The reproducibility and reliability of our expression data
were tested using the BeadStudio scatter plot analysis
function to calculate the correlation coefficient (R2) of our
gene expression profiles between technical replica,
between sham-operated and control spinal cord tissues
and between the thoracic and lumbar regions dissected
from the spinal cord of the same SOD1 G93A mutant rats.
These correlation analyses should demonstrate a signifi-
cant level of similarity between the gene expression pro-
files under investigation (expressed by R2 close to the
identity value of 1). The highest correlation coefficient of
R2: 0.9872 was detected, as expected, in the technical rep-
lica. Scatter plot correlation analysis (Table 1) of the tho-
racic and lumbar spinal cord expression profiles at 10
weeks of age, at onset and at end-stage disease, yielded
correlation coefficients of 0.944, 0.947 and 0.932 respec-
tively, indicating that the Bead array analysis captured the
expected similarity between adjacent segments of the
same tissue in the SOD1 G93A mutant rat. However, the
degree of correlation diminished at end-stage disease,
compared to the pre-symptomatic and the disease-onset
stages. While the two segments of the same tissue remain
overall very similar on a molecular level at a specific time
point (as demonstrated by the high R2  values), their
molecular profiles diverge at the end-stage disease, possi-
bly as a result of the different regional effects that the dis-
ease process has in lumbar and thoracic cord segments in
hindlimb onset mutant rats. The correlation analysis
between sham-operated and wild-type 10-week old tho-
Details of the GO categories composition of the functional heading "Development, growth" (23 GO categories, see also Figure  2A) Figure 3
Details of the GO categories composition of the functional heading "Development, growth" (23 GO catego-
ries, see also Figure 2A). The underlined GO categories at the top of the graph are the parent categories, which have a 
broad functional role. The bottom of the graph reports the children categories, with fewer genes and more defined functional 
roles in the development of specific cell types (these genes are represented also in the parent categories). In both the com-
pression and the G93A SOD1 mutant spinal cord, the selected GO categories FDRs are represented and the average of the 
FDR values for all the GO categories at each time points are represented at the bottom row with the colour code used in Fig-
ure 2.BMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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racic cord samples identified a R2 of 0.962 at 4 hours and
of 0.973 at 30 minutes.
In this study, we have confirmed that our results repro-
duce the findings of a previous investigation performed
using a similar experimental platform of mild SCI and the
same time points for spinal cord gene expression analysis
in the post-injury phase [11]. The expression of two sub-
sets of genes included in GO categories/functional head-
ings that were respectively up-regulated and down-
regulated in our spinal cord compression experiment, was
retrieved from the gene expression dataset GDS339 pub-
lished by DiGiovanni et al. in Gene Expression Omnibus
(GEO) [11]. This dataset reports the gene expression anal-
ysis at the site of mild injury in rat spinal cord 30 minutes,
4 hours, 24 hours and 7 days after trauma. The first subset
included 80 genes belonging to GO categories activated at
the 4 and 24 hours time-points from injury in our experi-
ments (Figure 2A and Supplementary material 2A;
GO:0001525_angiogenesis,
GO:0045896_regulation_of_transcription__mitotic,
GO:0007155_cell_adhesion, GO:0007049_cell_cycle;
GO:0000278_mitotic_cell_cycle,
GO:0016477_cell_migration,
GO:0042551_neuron_maturation;
GO:0030154_cell_differentiation). The second subset
included 51 genes that are part of the gene categories
becoming down-regulated at 7 days from injury in our
experiments (Figure 2D and Supplementary material 2D;
GO:0007267_cell-cell_signaling;
GO:0007268_synaptic_transmission;
GO:0019226_transmission_of_nerve_impulse;
GO:0005856_cytoskeleton;
GO:0005886_plasma_membrane;
GO:0031410_cytoplasmic_vesicle;
GO:0045104_intermediate_filament_cytoskeleton_organ
ization_and_biogenesis and GO:0006694_steroid_biosy
nthesis).
The expression of the first subset of 80 genes taken from
the data published by Di Giovanni et al. (2003) is shown
in Figure 4. In each of the 4 plots, the gene expression val-
ues (intensity) are plotted against control array experi-
ments and each plot shows a different time point after
SCI. It can be seen that the gene expression of the test-
genes increases significantly in contused spinal cord at 4
and 24 hours after injury (R2: 0.1859 and R2: 0.0936
respectively), compared to the 30 minutes and 7 days time
points (R2: 0.4021 and R2: 0.4505 respectively). The cor-
relation coefficients indicate more dispersion at 4 and 24
hours and the dots appear above the line of identity and
close to the Y axis (Figure 4). These findings are in line
with the substantial activation of the related gene catego-
ries/functional headings identified in our study at the
same time points after compression injury (Figure 2A).
The expression of the second subset of 51 genes is
reported in Figure 5. The expression of the test-genes is
marginally reduced at 24 hours and 7 days from mild
injury (R2: 0.876 and R2: 0.880 respectively), compared to
the 30 minutes and 4 hours time points (R2: 0.946 and
R2: 0.957 respectively). In the scatter plot analysis, dots
Table 1: Correlation analyses by scatter plot of Bead-array replica experiments (BeadStudio 3).
G93A SOD1
10 weeks (L)
G93A SOD1
onset (L)
G93A SOD1
late-stage (L)
SCC
30 min.*
WT
10 weeks (T)
G93A SOD1
10-weeks (T)
0.944
G93A SOD1
onset (T)
0.947
G93A SOD1
late-stage (T)
0.932
SCC
30 min.*
0.982
Sham WT
30 min.
0.973
Sham WT
4 hours
0.962
Correlation coefficients (scatter plot analysis, BeadStudio 3) obtained comparing the thoracic to the lumbar spinal cord expression profiles from 
the same G93A SOD1 mutant spinal cord tissue at a pre-symptomatic stage, at onset and at end-stage disease (R2: 0.944, 0.947 and 0.932 
respectively) and comparing sham-operated and naive thoracic cord samples from wild type littermates at 30 minutes (R2: 0.973) and at 4 hours (R2: 
0.962) from surgery. A technical replica experiment is also reported, based on the comparison of the gene expression profiles obtained from the 
same spinal cord sample (extracted at 30 minutes from compression injury) used to hybridize two separate Bead arrays (R2: 0.9872*). The 
significant R2 levels indicate that the Bead array technique reproduces the expected similarity of the samples chosen for the correlation analyses.
*: technical replica using RNA extracted from thoracic cord 30 minutes after injury (hybridization of two arrays in the same Bead Chip). The R2 is 
reported in bold.
L: lumbar
T: thoracicBMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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representing the 51 genes are mostly below the identity
line and close to the X axis at the 24 hours and 7 days time
points (Figure 5). The gene expression data taken from
DiGiovanni et al. [11] confirm the down-regulation of the
related gene categories/functional headings at the same
time points from compression injury in our study (Figure
2D).
Our study is primarily focused on the behaviour of molec-
ular pathways across different experimental paradigms
and not on the regulation of specific gene candidates.
Therefore, we have not pursued any further confirmation
of single transcripts differential regulation at RNA or pro-
tein levels.
Common molecular features in trauma and genetically-
induced spinal cord degeneration
Almost all differentially regulated GO categories in our
study were found at 24 hours and 7 days post-SCC and at
end-stage disease in the SOD1 G93A mutant spinal cord
(Figure 2; see Additional files 1, 2, 3 and 4). In both ani-
mal models at these time-points and at an earlier stage
after SCC, we have observed the up-regulation of struc-
tural and cytoskeletal genes and of factors involved in a
Scatter plots showing the time-dependent up-regulation in spinal cord tissue at different time points after mild injury of a sub- set of 80 genes, according to the results of a published gene expression analysis from Di Giovanni et al Figure 4
Scatter plots showing the time-dependent up-regulation in spinal cord tissue at different time points after mild 
injury of a subset of 80 genes, according to the results of a published gene expression analysis from Di Giovanni 
et al. [gene expression dataset: GEO-GDS339; [11]]. These genes belong to GO categories (e.g. GO:0001525_angiogenesis, 
GO:0045896_regulation_of_transcription__mitotic, adhesion, GO:0007155_cell_adhesion, GO:0007049_cell_cycle, 
GO:0000278_mitotic_cell_cycle, GO:0016477_cell_migration, GO:0042551_neuron_maturation and 
GO:0030154_cell_differentiation) that have been found, in our spinal cord compression experiments, to undergo the same 
pattern of differential regulation shown here in the DiGiovanni dataset at 4 and 24 hours after compression injury. Each gene 
expression value (intensity) was calculated as the average of 4 array experiments (GDS339) and represented in a scatter plot 
against the average value of 4 control array experiments [11]. The correlation analysis confirms that the findings of our gene 
expression analysis in compressed spinal cord reproduce previous observations obtained using a similar experimental paradigm 
of spinal cord injury.
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variety of biological processes (Figure 2B; see Additional
file 2). The structural genes which become up-regulated in
both post-injury and in the SOD1 G93A mutant spinal
cord, such as those encoding for proteins within microtu-
bules, cell organelle and extracellular matrix may be cru-
cial in the cascade of molecular events leading to
neurodegeneration or may be important determinants in
the induction of a condition like ALS following mechani-
cal injury. It is now becoming increasingly clear that nerv-
ous tissue degeneration in ALS may derive from an
inefficient or delayed clearance of different structural
components, including neurofilaments [19]. In line with
these observations, we have also identified an increase of
protein folding activity induced by trauma and by the
SOD1 G93A mutation (Figure 2B; "protein folding": 2 GO
categories). We may postulate that trauma facilitates pro-
tein folding and the deposition of protein aggregates,
which in turn may interfere with cellular functions such as
axonal transport. The trauma-induced increase in struc-
tural protein content and aggregation may initiate a cas-
cade of events leading to ALS. It is interesting to observe
that in our gene ontology data, GO categories involved in
microtubule formation appear to be activated also in
sham-operated spinal cord at 4 hours, but not those cate-
gories that orchestrate protein folding. This finding may
suggest that the mere production of neurofilaments in spi-
nal cord tissue increases as a result of the stress induced by
simple laminectomy and not necessarily following a
Similarly to what shown in Figure 4, the scatter plots indicate the time-dependent down-regulation in spinal cord of 56 gene  candidates identified in the experiment of mild compression injury published by DiGiovanni et al Figure 5
Similarly to what shown in Figure 4, the scatter plots indicate the time-dependent down-regulation in spinal 
cord of 56 gene candidates identified in the experiment of mild compression injury published by DiGiovanni et 
al. [gene expression dataset: GEO-GDS339; [11]]. These genes are included within GO categories and functional headings (e.g. 
GO:0007267_cell-cell_signaling, GO:0007268_synaptic_transmission, GO:0019226_transmission_of_nerve_impulse, 
GO:0005856_cytoskeleton; GO:0005886_plasma_membrane, GO:0031410_cytoplasmic_vesicle, 
GO:0045104_intermediate_filament_cytoskeleton_organization_and_biogene, GO:0006694_steroid_biosynthesis) that 
undergo down-regulation (particularly at 7 days after injury) in our spinal cord compression experiment. The pattern of differ-
ential regulation expressed as correlation coefficients (R2) in both subsets of up-regulated (Figure 4) and down-regulated genes 
according to the GDS339 expression dataset from Di Giovanni et al., correspond to the type and temporal pattern of differen-
tial regulation of the related GO categories and functional headings identified in our ontological analysis.
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direct traumatic injury. A recent retrospective and exten-
sive epidemiological study on the incidence of ALS in a
large area of Japan has demonstrated the relevance of
environmental factors in the pathogenesis of ALS [20].
These include not only cervical spondylosis and spinal
spondylotic myelopathy, but also a history of bone frac-
ture and of surgical treatment.
A large-scale activation of gene categories involved in the
modulation of apoptosis (10 GO categories) and of oxi-
doreductase activity (4 GO categories) appears to be a
common denominator of the two experimental para-
digms (Figure 2B; see Additional file 2). However, it is
worth noticing that both types of response remain over-
represented in the SOD1 G93A mutant spinal cord at a
final disease stage, whereas this apoptotic signal is largely
absent in the molecular profile of spinal cord compres-
sion at 7 days from injury. Spinal cord at 7 days after com-
pression and in SOD1 G93A animals throughout the
disease development appears to harbour a pattern of dif-
fuse inflammatory responses, including activation of
MHC, T-cell and complement factors. The early activation
of factors involved in prostanoid metabolism in both
experimental models is also in line with the surge of pro-
inflammatory activity in spinal cord. A recent study has
shown how astrocytes are directly involved in the complex
regulation of proinflammatory prostanoids in the CNS,
under stressful conditions induced by administration of
lipopolysaccharide. Since astrogliosis is one of the main
pathological features in the development of ALS and in
the spinal cord response to injury, the activation of these
pro-inflammatory factors may be a potential target of
pharmachological intervention in both pathological con-
ditions [21]. Altered brain prostanoid metabolism has
already been implicated in ALS [22] and in the develop-
ment of other neurological disorders including fronto-
temporal dementia and Alzheimer's disease [23,24].
Distinctive gene expression changes in spinal cord 
compression and G93A SOD1 mutant spinal cord: 
molecular and functional correlation
The ontological characterisation of the time-dependent
gene expression changes in the spinal cord from the com-
pression and G93A SOD1 animal models has also dis-
closed patterns of differential expression that are unique
or predominantly represented in each experimental
model. In this study, we have identified these distinctive
molecular fingerprints and evaluated the related behav-
ioural and functional changes in the animal model. In spi-
nal cord subjected to compression injury, we have
detected the up-regulation of a large array of growth fac-
tors included in 24 GO categories ("Development,
growth" contains 24 GO categories, the largest number
among all functional headings, Figure 3). Other gene cat-
egories including the bone morphogenetic proteins and
factors involved in lipid metabolism and cholesterol
transport which were found to become activated in our
compression experiment are likely to have a similar pro-
survival function. This powerful drive towards cell sur-
vival seems to be present from 4 hours after mechanical
injury and to increase at the 7-day time point in the SCC
experiment, whereas the SOD1 G93A mutant spinal cord
appears to up-regulate growth factors only at disease
onset. In SCC, this early surge of growth factors may coun-
ter the reported activation of apoptotic genes, which
appears to reduce significantly after the 24-hour time
point (Figure 2A/B; see Additional files 1, 2). The change
in the relative balance between the expression of pro-sur-
vival and pro-apoptotic gene candidates may support the
remarkable functional improvement in the animals sub-
jected to SCC observed between 24 and 48 hours from
compression (Figure 1C), whereas the persistently high
level of expression of genes promoting apoptosis in the
advanced stage of the disease in the G93A SOD1 mutants,
coupled with a weaker and transitory activation of growth
factors may explain the pattern of irreversible degenera-
tion and functional decline in the transgenic animal.
During the highest level of functional recovery, between
24 and 48 hours after compression injury, we have also
detected a spinal cord over-expression of GO categories
that supervise cell cycle, mitotic transcription, adhesion,
cell migration and taxis, angiogenesis and of S100A/
Integrin/Polysaccharide binding (Figure 2A; see Addi-
tional file 1). The combination of these molecular
responses appears to be unique to the trauma model (Fig-
ure 2A; 24 hours and 7 days time points after injury). It is
possible that the majority of these molecular pathways are
synergistic in maintaining or restoring tissue integrity,
antagonising the effect of other cytotoxic molecular
responses. For example, the gene candidates within the
GO:0045896 category (_regulation_of_transcription__
mitotic) are up-regulated at 4 and 24 hours from compres-
sion and are known to be involved in transcriptional reg-
ulation, increasing cell mitotic rate under conditions of
injury [25]. The up-regulation of gene categories that pro-
mote cell migration/taxis, chemotaxis and phagocytosis
(Figure 2A, see Additional file 1: 14 GO categories) is
another distinctive feature of the effects of mechanical
trauma in spinal cord. This is a chemoattractant-mediated
inflammatory response which is known to lead to the
release of nitric oxide (NO) and to be associated with sec-
ondary degeneration [26]. Our investigation shows how 9
GO categories representing different classes of chemok-
ines and 8 GO categories of gene candidates involved in
cell migration are significantly activated in all the time
points considered after compression injury (Figure 2A; see
Additional file 1), while the same chemokine pathways
appear activated only at end-stage disease in the spinal
cord from the G93A SOD1 gene mutant. These findingsBMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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may suggest that any intervention of "vasculature remod-
elling" in spinal cord injury, enhancing blood flow and
oxygen supply to the injury site may contribute to the
functional improvement of damaged tissue. Another find-
ing in keeping with the importance of angiogenic factors
in SCC is the involvement of genes within the integrin-
binding GO category. In our study, we have identified a
dramatic down-regulation of this GO category at 30
minute from SCC coinciding with profound functional
decline, followed by a 7-days significant over-expression
of this gene category, while the animal model is in func-
tional recovery. Integrins have been recognised as poten-
tial therapeutic targets to protect the vasculature and/or
promote angiogenesis, as their activation can promote
tubule formation and survival of endothelial cells in vitro
[27]. Our experimental model of spinal cord compression
seems to suggest that the activation of mechanisms facili-
tating tissue regeneration in injured spinal cord may be
antagonised by the activation of cell-cycle pathways. At
least 10 GO categories enlisting genes involved in differ-
ent aspects of cell-cycle regulation become activated dur-
ing the recovery phase following spinal cord compression
(Figure 2A; see Additional file 1), whereas this molecular
response does not seem to go above detection levels in the
G93A SOD1 mutant spinal cord. Previous studies have
shown how cell-cycle genes which become activated in
both neuronal and glial cells following spinal cord injury
cause neuronal and oligodendroglial apoptosis, glial scar
formation and microglia activation (DiGiovanni et al.
2003). Treatment of SCI with the cell cycle inhibitor fla-
vopiridol has been shown to improve functional recovery
and to reduce lesion volume [28].
Another gene expression feature in the spinal cord from
our trauma model which goes undetected in the SOD1
G93A mutant spinal cord is the remarkable down-regula-
tion of a large array of genes involved in intracellular and
in cell-cell signalling, along with gene factors crucial to
ion and neurotransmitter transport and in synaptic struc-
ture (Figure 2D; see Additional file 4). The silencing of
these important components of cell signalling at 7 days
from compression injury is confirmed by our cross-analy-
sis of the gene expression data from DiGiovanni et al.
[11]. Recent experimental evidence has portrayed astro-
cytes as essential supporters of neuronal function and
potential key players in the development of neurological
and psychiatric disorders, for their ability to sense and
integrate synaptic activity and to release gliotransmitters
(e.g. glutamate, d-serine and ATP) [29]. Mechanical injury
may specifically affect gliotransmission, causing the
reduction of ion and neurotransmitter transport in the
affected tissue. The ultimate effect on neuronal functional
integrity of this generalised decline of cell-cell transmis-
sion in the traumatised cord at 7 days from impact is dif-
ficult to appreciate. It may be that the potential
detrimental effect on cell survival of this phenomenon is
counterbalanced by the reported activation of transcripts
promoting cell growth and differentiation at this time
point from injury.
Spinal cord degeneration and cytoskeletal changes
We have detected different patterns of expression of
cytoskeletal and structural components in the two experi-
mental models of spinal cord degeneration. In spinal cord
after compression injury and throughout the disease
development in SOD1 G93A mutant animals, factors
involved in the formation of microtubule and cell
organelles along with parts of the extra-cellular matrix
appear to be variably up-regulated (Figure 2B; see Addi-
tional file 2). Our study shows also that cytoskeletal com-
ponents such as actin and intermediate filaments, vesicle
and synaptic proteins, muscle filaments and cell-matrix
junction gene candidates become significantly down-reg-
ulated in spinal cord at 7 days after compression injury.
We have confirmed that this down-regulation of structural
genes in spinal cord has also been identified by another
investigation employing a rat model of mild injury, at 7
days from the impact [[11]; Figure 5]. We could speculate
that clearance of molecules that may potentially contrib-
ute to the formation of cell aggregates or be part of mal-
functioning cell organelles, is part of a general process of
functional restoration after traumatic injury. SOD1 G93A
mutant spinal cord at end-stage disease does also show
reduced expression of cytoskeletal genes, including inter-
mediate neurofilaments which are essential for axonal
integrity. The development of the disease in the SOD1
G93A model of ALS has recently been shown to result
from damage to the distal motor axon and not only from
activation of death pathways within the cell body [30].
The early involvement of axonal function and structure in
conditions such as ALS has suggested that those axonal
components that become deficient in the affected tissue at
an early disease stage may be detected in biological fluids
from ALS patients and used as biological markers of dis-
ease. Various studies have shown that slow destruction of
neurons in most neurodegenerative disorders causes an
elevation of neurofilament levels in the cerebrospinal
fluid. Rosengren et al., found very high levels of neurofil-
ament light chain in those patients with upper motor neu-
ron involvement as opposed to lower motor neuron
involvement alone [31]. CSF neurofilament heavy chain
expression is also known to increase in proportion to the
extent of upper motor neuron involvement and with dis-
ease severity [32].
Changes in the expression of actin and of those gene can-
didates involved in its metabolism appear as distinguish-
ing features in the G93A SOD1 mutant spinal cord. At
least 15 GO categories involved in actin protein polymer-
ization become up-regulated at end-stage disease (FigureBMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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2C; see Additional file 3). However, in both trauma and
genetically-induced spinal cord degeneration it is possible
to detect an early down-regulation of actin filaments
including actinin, alpha 2 and 3 (ACTN2, ACTN3) and
actin, alpha 1 (ACTA1) (GO:0005884_actin_filament
Gene Category). The SOD1  mutated protein physically
binds to actin, causing cytoskeletal and cell-cycle abnor-
malities with growth retardation, as recently shown by
transfection with a human mutated SOD1 gene of neu-
roblastoma Neuro-2a cells [33].
These findings seem to support the hypothesis that spinal
cord functional decline, whatever the initial pathological
trigger, may be closely related to the abnormal homeosta-
sis of a number of structural components, to an increase
of protein folding and to the inability of the affected tissue
of clearing aggregates of cytoskeletal proteins. In the
SOD1 G93A model of ALS, the differential expression of
various cytoskeletal and axonal proteins at different stages
of the disease development makes the interpretation of
the pathogenic role of these changes rather difficult. The
down-regulation of actin, muscle and intermediate fila-
ments at an early stage and throughout the disease process
and the differential regulation of other cytoskeletal pro-
teins central to the microtubule architecture towards the
disease end-stage may be interpreted as one of the causa-
tive factors of neurodegeneration or simply be a conse-
quence of other primary disease mechanisms such as
slowing of axonal flow.
Inflammatory and immune responses in spinal cord degeneration
In both types of experimental spinal cord degeneration,
we have identified inflammatory responses involving the
activation of the MHC and complement complexes and of
the innate and T-cell immunity (Figure 2B; see Additional
file 2). A wealth of experimental data supports the concept
that neuroinflammation in ALS spinal cord and cortex is
based on an innate immune response regulated by macro-
phages and mast cells but also, on the contribute of an
adaptive T-cell mediated immune response [34]. In line
with our findings, the up-regulation of genes crucial to a
T-cell-mediated inflammatory reaction has been already
described in the spinal cord from patients with ALS. The
ultimate effect on neurons and the interaction with acti-
vated microglia through secretion of cytokines that T-cells
are supposed to exert is still a matter of intense investiga-
tion [35]. Whilst our study has clearly detected major
analogies in the activation of inflammatory and immune
factors in the spinal cord from two very different animal
models of spinal cord degeneration, differences have also
emerged which may help to characterise the specificity of
each pathological process. For example, interleukine-6,
TNF-alpha and other gene candidates supporting
machrophage activation are significantly more expressed
in injured spinal cord. This discrepancy may be related to
the nature of the bioinformatic approach we have used,
which focus on the significance of the activation of GO
categories as entities (according to the level of enrichment
of differentially regulated genes) rather than on the con-
tribution and extent of differential regulation of single
and potentially more crucial gene candidates.
The persistent activation of chemokines is another exam-
ple of how an enhanced modulation of the inflammatory
response is a characteristic feature of the spinal cord after
compression (Figure 2A; see Additional file 1). The chem-
okines included in three GO categories in fact become up-
regulated only at end-stage disease in the G93A SOD1
mutant spinal cord and with a lesser degree of statistical
significance. The spatial and temporal distribution of
proinflammatory cytokines and their cellular source has
been previously investigated in a model of spinal cord
injury [37]. Following mechanical trauma, it appears that
all classes of neural cells initially contribute to inflamma-
tion, whereas recruited immune cells mostly determine its
maintenance at later time points. With regard to the G93A
SOD1 mutant spinal cord, our study suggests that the
main inflammatory changes are present at end stage dis-
ease and are characterised by an adaptive T-cell mediated
response, buffered by a modest increase of cytokine
expression. These data on trauma and genetically-induced
spinal cord degeneration may guide the timing and the
nature of potential treatment strategies targeting the
inflammatory response, once the effects on glial cells and
neurons of these tissue responses are better understood.
Conclusion
In this study, we have compared the gene expression
changes characterising two models of spinal cord degener-
ation, using a bioinformatic tool that allows the simulta-
neous integration of expression data from different
experimental sources, into categories containing ontolog-
ically comparable genes. The functional assessment of dis-
ease progression in the two animal models has enhanced
our understanding of the significance of the dominant
patterns of time-dependent gene expression changes. Our
investigation seems to suggest that the remarkable func-
tional improvement after mild spinal cord compression is
sustained at a molecular level, by a powerful early onset
surge of growth-promoting factors, possibly overriding
the detrimental effect on cell survival that pro-apoptotic
signals may exert. In contrast, the spinal cord molecular
profile in the SOD1 G93A mutant rat undergoing func-
tional decline appears to be dominated by pro-apoptotic
and stress molecular responses, which are unchallenged
by other major pro-survival signals. Our findings also sup-
port the role that neurofilament expression and aggrega-
tion may have in nervous tissue degeneration caused by
different modalities of stress, as previously reported for
ALS [37]. We could speculate that one of the mechanismBMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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involved in the induction of the irreversible neurodegen-
eration observed in ALS after mechanical trauma, could be
the over-expression of structural genes in individuals with
a genetically-determined inability of clearing these prod-
ucts in a way that would prevent the formation of cyto-
toxic cellular aggregates.
Our study shows how compression injury creates a partic-
ularly dynamic environment of molecular changes which
may be pharmachologically modified for therapeutic pur-
poses. Treatment strategies in SCI could rely on the block-
ade of factors involved in prostanoid metabolism and
cell-cycle, or eventually, on the early enhancement of
integrin and angiogenic factors. While we have concen-
trated in this study on a functional and molecular evalua-
tion of the most represented gene expression changes in
the experimental models, further investigations will be
required to fine-tune our experimental approach to the
relevance of single biological signals in the pathogenesis
of spinal cord degeneration.
Methods
Animals
5 male Sprague-Dawley rats heterozygous for the G93A
SOD1 gene mutation (Emerging Model 2148 Het Male,
TACONIC US; Wyeth and Amyotrophic Lateral Sclerosis
Association 2002) and 5 wild type females were used for
a breeding project at Taconic Breeding Services (USA). An
average of 5/6 pups per breeding pair were kept in sepa-
rate cages and genotyped using a Multiplex Protocol for
Human SOD (Taconic US). Male pups were discarded at
weaning whereas a total of 20 heterozygous and 40 wild
type females pups were kept in separate holding cages and
shipped to our laboratories at 6 weeks of age. Following
shipments, rats were housed in a pathogen-free animal
facility at room temperature (21°C) under a 12 hour
light-dark cycle. All animal procedures were conducted
according to the Animals Scientific Procedures Act (1986),
approved by the United Kingdom Home Office. 5 hetero-
zygote female rats and 5 wild-type female littermates were
sacrificed at 10 weeks of age and the thoracic/lumbar cord
regions harvested for further analysis. Prior to sacrifice,
the remaining rats were subjected to the behavioral and
weight measurements as reported below.
Laminectomy and spinal cord compression
Laminectomy with or without spinal cord compression
(SCC) was performed in 24 wild type (WT) female rats at
10 weeks of age. Rats were anaesthetized in a fume box
with a mixture of isoflurane (2.5%), oxygen and nitrous
oxide (1:1 ratio) at a flow rate of 750–1000 mL/min. The
skin and muscle surrounding spinal cord (T10 – L1) were
incised and a laminectomy was performed at T12 level
without damaging the dura. The compression injury was
performed in 18 of the 24 rats by statically applying a 35
g. weight for 5 min, on a platform (area 2 × 5 mm2) resting
on the exposed T12 spinal segment. In all animals sub-
jected to surgery, the muscle layers were sutured and the
skin was closed with wound clips. After surgery, animals
were placed in warmed cages to recover from anaesthesia.
Manual bladder expression was performed twice a day for
the first week and once a week thereafter until establish-
ment of self-voiding reflex. Rats were sacrificed by asphyx-
iation with carbon dioxide after surgery at the following
time points: 5 rats 30 minutes after SCC and 3 rats 30
minutes after laminectomy, 4 rats 4 hours after SCC and 3
rats 4 hours after laminectomy, 4 rats 24 h after SCC and
5 rats 7 days after SCC. Spinal cord samples at T12 level
were dissected after sacrifice and immediately frozen in
liquid nitrogen.
Behavioral analysis and weight measurements
The level of functional recovery in WT female rats after
spinal cord compression (SCC) was scored at 4 hours, 24
hours and 7 days from injury using the Basso, Beattie, and
Bresnahan (BBB) open-field locomotor rating scale as pre-
viously reported [18]. The BBB scoring for each animal
right and left hindlimb was graded at the defined time
points by two independent blinded observers.
The rat model of ALS carrying the G93A SOD1 gene muta-
tion is known to develop subtle signs of motor impair-
ment, with either hindlimb or forelimb distribution at
disease presentation and to progress to end-stage disease
in approximately 1 or 2 weeks from disease onset [38]. We
have used body-weight measurements and behavioural
analysis in 12 SOD1 G93A mutant rats with either hind-
limb or forelimb onset and in 12 WT age-matched litter-
mates as previously reported [11]. The rats were weighed
using an electronic scale three times a week, from the age
of 7 weeks to end-stage disease. In the SOD1 G93A mutant
animal group, the maximum body weight reached by the
animal before disease onset was set at 100%. The end-
stage disease was defined as a reduction of 25–30% from
the maximum body weight (normally this was accompa-
nied by a consistent loss of the righting reflex; i.e. the fail-
ure of the animal to right itself within 30 seconds when
placed on its side).
Of the 12 SOD1 G93A mutant rats used for weight meas-
urements, 4 rats showing subtle signs of hindlimb paraly-
sis at disease onset and 4 WT age-matched littermates were
also subjected to serial evaluation of locomotor activity in
an open field (80 × 30 × 30 cm polypropylene box),
including the determination of the average number of
rearing episodes and of the average immobility time. Each
rat was video-recorded for 3 minutes three times a week.
At disease onset (first signs of paralysis) and at end stage
disease, average immobility time and average rearing epi-
sodes were recorded for each WT and G93A SOD1 mutantBMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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rat by independent investigators in two subsequent video
clips.
The 4 WT and the 4 hindlimb-onset G93A SOD1 mutant
rats subjected to behavioural analysis and weight meas-
urements were sacrificed at end-stage disease. A further 4
G93A SOD1 mutant rats with early hindlimb paralysis
were sacrificed at disease onset together with 4 WT age-
matched littermates. Another group of 4 G93A SOD1
mutant rats and 4 WT age-matched littermates were sacri-
ficed at a presymtomatic stage (10 weeks of age), when
hindlimb or forelimb disease onset is clearly not predict-
able. Thoracic and lumbar regions of the spinal cord tissue
were harvested and immediately frozen in liquid nitro-
gen. Spinal cord tissue from the WT rats at 10 weeks of age
was also used as control group in the experiment compar-
ing the gene expression profile in thoracic cord at different
time points after compression with uninjured tissue.
Bead array gene expression analysis
The RNA expression profiles of thoracic and lumbar spi-
nal cord samples from the SOD1 G93A mutant rats and
from WT littermates were obtained using large-scale gene
expression analysis by Bead array Technology (Illumina,
San Diego, USA). The same technique was employed to
analyze the gene expression profile in thoracic spinal cord
collected from WT female rats after mild spinal cord com-
pression and after laminectomy. Spinal cord samples were
collected for gene expression analysis from a total of 52
animals. RNA was extracted from the spinal cord tracts
using the SV total RNA isolation system (Promega, UK)
and quantified using a Nanodrop ND-1000 spectropho-
tometer. RNA quality was checked using the Agilent bio-
analyser system (Agilent). RNA samples from the same
experimental condition, genetic type (WT and G93A
SOD1 mutant), time-point and spinal cord region were
pooled together, for a total of 12 pools (4 pooled samples
from the 30 min, 4 hours, 24 hours and 7 days time points
after compression, 2 pooled samples from the 30 min and
4 hours time points after laminectomy, 3 pooled samples
from pre-symptomatic, onset and end-stage G93A SOD1
mutant rats and 3 pooled samples from WT littermates at
the same time points in the disease progression of the
mutant rats). cRNA labeling was performed with 750 ng
of total pooled RNA, using the Ambion Total Prep kit.
cRNA purity and labelling was checked using the Nano-
drop and Agilent bioanalyser. To ensure homogeneous
conditions for the gene expression experiments, 500 ng
from each of the 12 RNA pools were hybridised simulta-
neously to the 12 separate arrays contained in the same
RatRef-12 Expression BeadChip, as per Illumina protocol
(Illumina, San Diego, USA). A separate Beadchip was used
to perform a technical replica experiment, testing the
same pooled RNA sample with two separate arrays and to
test pooled lumbar cord samples from G93A SOD1
mutant rats and from WT littermates, at 10 weeks of age,
at onset and at end-stage disease.
Weighted averages of pixel intensities for each bead (local
background was subtracted) and the relative p-value of
detection were obtained through the workflow station
(BeadArray Reader) and output files were analyzed using
BeadStudio-3 (Illumina, San Diego, USA). Normalized
expression data were obtained using the rank-invariant
algorithm, to remove systematic variation of non-biologi-
cal origin (BeadStudio-3). BeadStudio-3 was also used to
test differential expression between RNA samples from
the G93A SOD1 mutant and the WT rats and between
RNA samples from injured/sham-operated animals and
healthy rats at the chosen time points and spinal cord lev-
els. Stringent data of differential expression were obtained
using a false discovery rate through p-value adjustment.
Fold enrichment values (experiment vs control) were used
to obtain the list of candidates with greater than 1.5-fold
change.
Ontology analysis of the gene expression data
Text files containing lists of changed genes (i.e. genes that
were up-regulated or down-regulated compared to con-
trols) were prepared from the 9 sets of differentially
expressed genes obtained using Bead array analysis as
reported above. Each text file listed gene candidates sym-
bols according to the rat genome database. As recom-
mended by High-Throughput GoMiner http://
discover.nci.nih.gov/gominer/start.jsp, a flat +1 or -1
binary code was used to express up-regulation or down-
regulation of genes in injured and G93A SOD1 mutant
spinal cord (compared to healthy 10 weeks-old control
tissue in the compression experiment and to the WT litter-
mates in the G93A SOD1 mutant rats). The text files of
changed genes were submitted electronically to the High-
Throughput GoMiner database together with a list of all
the probes contained in the Illumina rat chip. GO catego-
ries were identified and sorted according to a level of sig-
nificance, based on a false discovery rate (FDR) threshold
of 0.05 and on the level of gene enrichment. A multiple
comparisons correction was used to eliminate GO catego-
ries that appeared significantly represented simply by
chance. The analysis software generated significantly
enriched GO categories with a FDR <0.05. It also provided
integrative results, showing the FDR values for a selected
GO category across all time points and experimental con-
ditions.
Gene ontology data have been represented in the follow-
ing way:
￿ We have grouped statistically significant down-regulated
or up-regulated (FDR< 0.05) GO categories under a gen-
eral functional heading (e.g. cell cycle, transcription,BMC Genomics 2008, 9:500 http://www.biomedcentral.com/1471-2164/9/500
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phagocytosis, angiogenesis etc.), considering the parent-
child relationship of these GO categories and their func-
tional similarity (most parent-child GO categories contain
the same redundant sets of genes).
￿ Visual integration of the results was obtained using clus-
tered image maps (CIMs) available from CIMminer and
Excel drawing plattform and the results have been dis-
played as heat maps.
Correlation analysis and cross-reference with other gene 
expression datasets
The reproducibility and reliability of the platform of gene
expression analysis we have employed in this study was
tested using the BeadStudio scatter plot analysis function
to calculate the correlation coefficient (R2) of our gene
expression profiles between technical replica, between
sham-operated and control tissues and between thoracic
and lumbar regions dissected from the same spinal cord
samples.
A cross-reference analysis to confirm the reproducibility
of our data was performed with the gene expression study
performed at the site of mild injury at 30 min., 4 hours, 24
hours and 7 days from the trauma by DiGiovanni et al.
[16]. Intensity values of two subsets of genes included in
GO categories found to be up-regulated and down-regu-
lated in a time-dependent manner after cord injury in our
experiments were obtained from the dataset published by
DiGiovanni et al. on Gene Expression Omnibus (GEO)
[Di Giovanni et al. 2005] (GDS339; GEO Series: GSE464).
The GDS339 expression data were obtained using an
Affymetrix GeneChip Rat Genome U34 Array Set (RG-
U34C, GEO GPL 85/86/87). Corresponding genes in the
Illumina and Affymetrix gene chips were identified
matching the different annotations to the same RefSeq
Transcript IDs. Using the GEO "Gene profile" search-
engine, we have calculated the average of the expression
values from 4 SCI and 4 control arrays, for the corre-
sponding genes in the datasets published by DiGiovanni
et al. [16]. Average expression values for the test genes in
the experiment from DiGiovanni et al. in injured and con-
trol spinal cord at each time point were reported as scatter
plot and the correlation coefficient calculated.
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